Lurbinectedin Specifically Triggers the Degradation of Phosphorylated RNA Polymerase II and the Formation of DNA Breaks in Cancer Cells von Santamaría Nuñez, Gema, Robles, Carlos Mario Genes, Giraudon, Christophe, Martínez-Leal, Juan Fernando, Compe, Emmanuel, Coin, Frédéric, Aviles, Pablo, Galmarini, Carlos María, Egly, Jean-Marc

Volltext

Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells von GERMANO, Giovanni, FRAPOLLI, Roberta, GRONCHI, Alessandro, VIRDIS, Emanuela, TARANTINO, Eva, PILOTTI, Silvana, GRECO, Angela, NEBULONI, Manuela, GALMARINI, Carlos Maria, TERCERO, Juan Carlos, MANTOVANI, Alberto, D'INCALCI, Maurizio, SIMONE, Matteo, ALLAVENA, Paola, TAVECCHIO, Michele, ERBA, Eugenio, PESCE, Samantha, PASQUALINI, Fabio, GROSSO, Federica, SANFILIPPO, Roberta, CASALI, Paolo G

Volltext

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound von Serova, Maria, de Gramont, Armand, Bieche, Ivan, Riveiro, Maria Eugenia, Galmarini, Carlos Maria, Aracil, Miguel, Jimeno, José, Faivre, Sandrine, Raymond, Eric

Volltext

Predicting disease progression and mortality in metastatic colorectal cancer patients (mCRC) through an artificial intelligence-based analytical tool von Galmarini, Carlos Maria, Lucius, Maximiliano

Volltext

Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine von Galmarini, Carlos María, Clarke, Marilyn L., Falette, Nicole, Puisieux, Alain, Mackey, John R., Dumontet, Charles

Volltext

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin von Ordóñez, José Luis, Amaral, Ana Teresa, Carcaboso, Angel M, Herrero-Martín, David, del Carmen García-Macías, María, Sevillano, Vicky, Alonso, Diego, Pascual-Pasto, Guillem, San-Segundo, Laura, Vila-Ubach, Monica, Rodrigues, Telmo, Fraile, Susana, Teodosio, Cristina, Mayo-Iscar, Agustín, Aracil, Miguel, Galmarini, Carlos María, Tirado, Oscar M, Mora, Jaume, de Álava, Enrique

Volltext

Profiling of clinically relevant subgroups of asymptomatic or mild-symptomatic metastatic castration-resistant prostate cancer (mCRPC) patients using PSA and testosterone levels an... von Dominguez Correa, Juan Manuel, Gomez del Campo, Pablo, Galmarini, Carlos Maria

Volltext

p53 as a target for anti-cancer drug development von Bouchet, Benjamin Pierre, de Fromentel, Claude Caron, Puisieux, Alain, Galmarini, Carlos María

Volltext

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene von Galmarini, Carlos María, Clarke, Marilyn L, Jordheim, Lars, Santos, Cheryl L, Cros, Emeline, Mackey, John R, Dumontet, Charles

Volltext

The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia von Galmarini, CM, Cros, E, Thomas, X, Jordheim, L, Dumontet, C

Volltext

Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine von Galmarini, Carlos María, Thomas, Xavier, Graham, Kathryn, El Jafaari, Assia, Cros, Emeline, Jordheim, Lars, Mackey, John R., Dumontet, Charles

Volltext

p21 Cip1 regulates cell–substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells von Bouchet, Benjamin Pierre, Fauvet, Frédérique, Grelier, Gaël, Galmarini, Carlos María, Puisieux, Alain

Volltext

Influence of p53 and p21WAF1 expression on sensitivity of cancer cells to cladribine von GALMARINI, Carlos Maria, VOORZANGER, Nathalie, FALETTE, Nicole, JORDHEIM, Lars, CROS, Emeline, PUISIEUX, Alain, DUMONTET, Charles

Volltext

Sensitization of ara‐C‐resistant lymphoma cells by a pronucleotide analogue von Galmarini, Carlos María, Clarke, Marilyn L., Santos, Cheryl L., Jordheim, Lars, Perigaud, Christian, Gosselin, Gilles, Cros, Emeline, Mackey, John R., Dumontet, Charles

Volltext

Mutational targets in colorectal cancer cells with microsatellite instability von Bertholon, Jacques, Wang, Qing, Galmarini, Carlos Maria, Puisieux, Alain

Volltext

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin von Ordóñez, José Luis, Amaral, Ana Teresa, Carcaboso, Angel M, Herrero-Martín, David, García-Macías, María Del Carmen, Sevillano, Vicky, Alonso, Diego, Pascual-Pasto, Guillem, San-Segundo, Laura, Vila-Ubach, Monica, Rodrigues, Telmo, Fraile, Susana, Teodosio, Cristina, Mayo-Iscar, Agustín, Aracil, Miguel, Galmarini, Carlos María, Tirado, Oscar M, Mora, Jaume, de Álava, Enrique

Volltext

Lurbinectedin induces depletion of tumor-associated macrophages (TAM), an essential component of its in vivo synergism with gemcitabine von Céspedes, María Virtudes, Guillén, María José, López-Casas, Pedro Pablo, Sarno, Francesca, Gallardo, Alberto, Álamo, Patricia, Cuevas, Carmen, Hidalgo, Manuel, Galmarini, Carlos María, Allavena, Paola, Avilés, Pablo, Mangues, Ramón

Volltext

p21Cip1 regulates cell–substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells von Bouchet, Benjamin Pierre, Fauvet, Frédérique, Grelier, Gaël, Galmarini, Carlos María, Puisieux, Alain

Volltext

COMBINATION THERAPY WITH A TOPOISOMERASE INHIBITOR von Moneo Ocana, Victoria, Guillén Navarro, Maria José, Avilés Marin, Pablo Manuel, Galmarini, Carlos Maria, Santamaria Nunez, Gema, Garcia Fernandez, Luis Francisco

Volltext bestellen

Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine von Galmarini, Carlos María, Voorzanger, Nathalie, Falette, Nicole, Jordheim, Lars, Cros, Emeline, Puisieux, Alain, Dumontet, Charles

Volltext